ESIAL temporal lobe epilepsy caused by HS is the most common medically refractory epilepsy syndrome. Satisfactory surgical results in terms of seizure control and cognitive improvement have clearly shown that MTLE/HS can be treated surgically. Although different surgical approaches have been used, the en bloc anterior temporal lobe resection ( It is also still unclear whether more limited surgical approaches produce equal success rates with respect to seizure control or better neuropsychological performance given that some claim that a more restricted resection, such as SelAH, results in better cognitive and seizure outcome than the resection that involves temporal neocortex, such as CorAH. [6] [7] [8] 16, 17, 22, 49 Other authors, including those of meta-analyses, did not find significant differences between the 2 surgical strategies. 2, 12, 35, 36, 42, 46 Because most centers use 1 preferred surgical approach for MTLE/HS, comparisons in terms of seizure outcome or cognitive changes can only be made with the results from other centers where different types of surgical strategies are Object. Resection strategies for the treatment of temporal lobe epilepsy (TLE) are a matter of discussion, and little information is available. The aim of this study was to compare seizure outcomes at the 5-year follow-up in patients with medically refractory unilateral mesial TLE (MTLE) due to hippocampal sclerosis (HS) who were treated using a cortical amygdalohippocampectomy (CorAH) or a selective AH (SelAH).
used. Thus, there is a paucity of data directly comparing SelAH and CorAH, or what is sometimes inappropriately called an "anterior temporal lobectomy," in terms of seizure outcome in a single center. To the best of our knowledge, the authors of only 5 studies have specifically compared seizure outcomes between SelAH and CorAH. 2, 3, 18, 35, 36 Some of these studies consisted of unequal numbers of patients in each group and short follow-up periods, 2, 3, 37 and some included patients with variable profiles of abnormalities in mesial structures 2 and different follow-up durations for each surgical group. 35 In this report, we selected equal numbers of patients who had a very homogeneous clinical picture with unilateral mesial temporal structure atrophy in MR imaging, were uniformly evaluated, underwent surgery through either an SelAH or CorAH, and underwent surgery performed by the same surgeon (A.O.). The comparison of 5-year seizure outcomes of these 2 surgical techniques is the subject of this report.
Clinical Material and Methods

Patient Population
Between 1986 and 2001, a total of 1077 patients underwent MTLE/HS surgery for medically intractable epilepsy syndrome at MNI. For this study the inclusion criteria were as follows: patients who 1) were Ն 16 years old; 2) had similar clinical profiles; 3) had complete clinical, neuroradiological, electrophysiological, neuropsychological, and surgical data; 4) had interictal and ictal scalp/sphenoidal and intracranial depth electrode EEG studies displaying unilateral independent anteromesial temporal epileptic discharges; 5) had MR imaging or histopathological findings characteristic of HS; 6) had not undergone reoperation; and 7) had a follow-up duration of Ն 5 years.
A list of all patients who underwent SelAH or CorAH between 1986 and 2001 was obtained from the epilepsy surgery database. All patients were seen at regular followup examinations by the referring neurologist and the surgeon. Data used for this analysis included the following clinical and demographic parameters: 1) age at seizure onset; 2) duration of epilepsy; 3) seizure frequency; 4) history of febrile seizure; 5) age at febrile seizure; 6) febrile seizure frequency; 7) duration of febrile seizure; 8) family history of seizure; 9) perinatal difficulties; 10) retardation; 11) history of status epilepticus; 12) head trauma; 13) secondary generalization; 14) history of meningitis/encephalitis; and 15) age at surgery.
First Cohort: Patients With CorAH
The first group included the first 50 patients who had undergone CorAH for MTLE/HS between March 1986 and January 1990 and who met our inclusion criteria. These individuals were selected from a total of 336 patients who had undergone surgery for intractable epilepsy. This group consisted of 19 male and 31 female patients with a mean age of 34.1 Ϯ 12.2 years. The mean patient age at seizure onset was 12.3 Ϯ 9 years, and all patients had complex partial seizures. Twenty patients in this cohort showed secondary generalization. Twenty-four patients underwent surgery on the right side and 26 patients on the left side.
Second Cohort: Patients With SelAH
The patients within the second group consisted of the first 50 patients who met our inclusion criteria and had undergone SelAH for MTLE/HS between January 1991 and April 2001. These individuals were drawn from a total of 741 patients who had undergone surgery for intractable epilepsy during the same period. This group consisted of 18 male and 32 female patients with mean age of 37.6 Ϯ 11.6 years. The mean patient age at seizure onset was 13.7 Ϯ 11 years. All had complex partial seizures and 23 patients had secondary generalization. Thirty-three patients underwent surgery on the right side and 27 on the left side.
Data regarding clinical and surgical variables in the 2 categories are listed in Table 1 .
Preoperative Evaluation
The preoperative evaluation of patients with medically refractory MTLE/HS included clinical, electrophysiological, imaging, and neuropsychological testing.
All patients underwent preoperative MR imaging assessments with the aid of a 1.5-T unit (Philips Gyroscan, Philips Medical Systems) including high-resolution T1-and T2-weighted and FLAIR studies. 
Surgical Procedures
Between 1986 and 1990 (when the first group underwent surgery), CorAH was considered the standard procedure at MNI for treatment of MTLE/HS. In CorAH, the goal is to perform a temporal neocortical resection, extending habitually 5 cm along the sylvian fissure and 5-5.5 cm along the floor of the middle fossa on the nondominant side and 4.5-5 cm in the dominant side, together with total or partial resection of the amygdala and uncus, and 2.5-3 cm removal of the hippocampus and parahippocampal gyrus. The surgical procedure has been described in detail elsewhere. 28-30, 37,38 Between 1991 and 2001 (when the second group underwent surgery), SelAH became the main surgical procedure. Briefly, transcortical SelAH, a procedure that has been described in greater detail elsewhere, 31 involves performing either a pterional craniotomy or a centered craniectomy with incision along the superior bank of the second temporal gyrus, subpial extension of this line of entry down along the superior temporal sulcus, across the temporal white matter, and into the temporal horn of the lateral ventricle. Inside the ventricle, the hippocampus, amygdala, entorhinal cortex, and uncus are resected by endopial technique performed by the same surgeon. 32 The steps of the procedure are performed with neuronavigation. The evolution of the surgical procedure paralleled the advancements in neuroimaging techniques and understanding of the epileptogenic basis of MTLE/HS. At MNI, our work with chronic depth electrode recording has confirmed the overwhelming predominance of temporal seizure onset from limbic structures. 33, 44 In patients with bitemporal epilepsy, it has been shown that the seizures arise predominantly from 1 temporal lobe and, within that temporal lobe, usually from the amygdala or hippocampus Ͼ 80% of the time. 44 Seizures of neocortical onset have been relatively rare, but are well documented. Relying more and more heavily on the morphological and electrophysiological changes seen in the limbic structures on MR imaging and EEG, we have performed more frequently the transcortical SelAH, which has become the procedure of choice in cases of mesiotemporal limbic epilepsy, that is, when the seizure pattern, the EEG findings, and the morphological stigmata are congruent. 31 
Histopathological Study
Hippocampal tissue sufficient for histopathological diagnosis was available in all patients. The resected specimens were histopathologically examined with previously described techniques. 19 A standard neuropathological protocol was generally used for all epilepsy cases. The qualitative assessment of pattern of cell loss, gliosis, and HS in hippocampal subfields CA1, CA3, and in the dentate gyrus was applied.
Postoperative Evaluation
Patients were discharged from the hospital and placed on therapeutic dosages of Ն 1 first-line antiepileptic drugs. Follow-up examinations were conducted at 6 weeks, 6 months, and yearly thereafter, either through outpatient visits or telephone interviews. Outcome was assessed independently by the neurological and neurosurgical teams. Patients and relatives were instructed to report seizure recurrences by telephone between scheduled outpatient visits, and these data were entered into a structured outcome data sheet. Interviews for follow-up purposes involved questioning patients or relatives about the recurrence of symptoms and signs suggestive of complex partial, partial motor, or generalized tonic-clonic seizures. All patients underwent MR imaging, scalp EEG, and neuropsychological evaluations during the follow-up period.
Outcome at the 5-year follow-up in relation to seizure control was based on the modified Engel classification, 9 using all 12 subclasses as follows: Class I, seizure free (Ia, completely seizure free since surgery; Ib, auras only since surgery; Ic, some seizures after surgery but seizure free for Ն 2 years; and Id, generalized convulsions following antiepileptic withdrawal only); Class II, rare seizures, with a maximum of 3 seizures per year (IIa, initially seizure free but currently has rare seizures; IIb, rare seizures since surgery; IIc, rare seizures for Ն 2 years; and IId, nocturnal seizures only, causing no disability); Class III, worthwhile improvement with a Ͼ 90% reduction of seizures (IIIa, worthwhile seizure reduction; and IIIb, prolonged seizurefree intervals for more than half of the follow-up but not Ͻ 2 years); and Class IV, no worthwhile improvement (Ͻ 90% reduction in seizure frequency; IVa, 60-90% reduction; IVb, no appreciable difference [Ͻ 60% reduction]). For categorical comparisons, this classification was divided into favorable (Engel Classes I and II) and unfavorable (Engel Classes III and IV) seizure outcome.
Statistical Analysis
All data collected from each patient were organized in a database (Excel, Microsoft Corp.). Numeric variables were provided as the mean Ϯ SD. For statistical analysis, we performed independent sample t-tests for comparing patient demographics and clinical characteristics between the 2 groups. We used chi-square analyses to compare seizure outcomes for different surgical procedures. For smaller contingency tables, we used the Fisher exact test. A probability value Ͻ 0.05 was considered statistically significant. All statistical calculations were performed using commercially available software (SPSS version 11.0.1, SPSS Inc.).
Results
The follow-up period was Ͼ 5 years for all patients, and data were available at the 5-year follow-up in all patients.
Clinical Findings and Demographic Data
Demographic and clinical data are summarized in Table  1 . Patients who underwent a CorAH or SelAH had very similar clinical and demographic characteristics. There was no statistically significant difference between the 2 groups in terms of patient demographics, seizure characteristics, patient history, surgical features, and follow-up duration.
Overall Seizure Outcome at 5 Years Postoperatively
At the 5-year follow-up, 86 patients (86%) were included in favorable seizure outcome (Engel Classes I and II) and 14 patients (14%) showed unfavorable seizure outcome (Engel Classes III and IV) (Fig. 1) . A total of 49 patients (49%) were completely seizure free (Engel Class Ia) without aura after tough questioning concerning of presence or absence of aura (Fig. 2) . No patient suffered worsening of seizure frequency or severity following surgery (Engel Class IVb).
Seizure Outcome for CorAH and SelAH at the 5-Year Follow-Up
A favorable seizure outcome at the 5-year follow-up was documented in 41 patients (82%) and 45 patients (90%) in the CorAH and SelAH groups, respectively (Fig. 3) . There was no statistical difference between the 2 different surgical approaches in terms of seizure outcome at the 5-year follow-up (p = 0.38, chi-square test). The numbers and equivalent percentages falling into each Engel class at the 5-year follow-up are listed in Table 2 . We also did not find a statistically significant difference between the 2 groups regarding each subclass at the 5-year follow-up. Although seizure freedom (Engel Class Ia) seemed to be attained more rapidly following SelAH than CorAH during the first 2-3 years, on long-term follow-up the percentages of patients in Classes I and II in both groups were similar. Therefore, at the 5-year follow-up the difference between groups was not statistically significant.
Postoperative Complications
There were neither intra-or postoperative deaths nor any significant neurological deficits in this series. Surgical complications occurred in 3 patients (6%) who underwent CorAH and in 1 patient (2%) who underwent SelAH. Nonoperative complications (pulmonary embolism) without sequelae occurred in only 2 patients (4%) in the CorAH group. The complications other than upper quadrantanopia were transitory and had resolved by the time of discharge from the hospital (Table 3) .
Discussion
In this study, we demonstrated that both surgical procedures are effective for patients with medically refractory MTLE/HS, and no significant difference was found in terms of seizure outcome at the 5-year follow-up.
Overall Seizure Outcome
The overall seizure outcome was consistent with that reported in the literature.
1,6-8,11,21,23,31,40,46-49 Recent review articles concerning MTLE/HS have demonstrated that the proportion of patients reported as seizure free 5 years postoperatively ranged from 56 to 66% and these rates vary by Յ 10% from year to year with no discernable pattern over time. Moreover, seizure freedom has been reported to be 52, 50, and 45% at 5, 7, and 10 years, respectively, after surgery. 21 A sharp decrease in seizure freedom during the 1st or 2nd postoperative year has also been reported. 21 In another meta-analysis, it was demonstrated that seizure freedom at the 1-year follow-up ranged from 53 to 80%, and the rate decreased to 52 and 58% at the 2-and 5-year follow-ups, respectively. 20 Additionally, KaplanMeier analysis of the probability of long-term seizure freedom showed that the probability of seizure freedom was 60.9% at 1 year postoperatively and decreased to 55.3% at 2 years. 20 At 5 years, the probability was 47.7%; at 10 years, 41%; and at 15 years, 36.8%. 20 Long-term studies of MTLE/HS revealed a lower seizure-freedom rate. 47 The authors of meta-analyses identified various issues when gathering the data, such as differences in definitions of outcome, types of patients included, and duration of follow-up. 20, 21, 47 Furthermore, longer follow-up was associated with lower rates of antiepileptic drug discontinuation, reflecting lower seizure-free rates over time. 20 Thus, longterm assessment of seizure outcome is essential after epilepsy surgery because of the nature of the condition and its intrinsic unpredictability, which causes irreversible damage. Consequently, results of studies dealing with relatively short-term outcomes should be interpreted cautiously.
Seizure Outcome in CorAH and SelAH
Our results demonstrated that there is no significant difference between CorAH and SelAH in terms of seizure outcome at the 5-year follow-up. It has been shown that both CorAH or anterior temporal resection (or what is sometimes inappropriately called a temporal lobectomy) and SelAH are effective and safe procedures in patients with intractable MTLE/HS. 2, 4, 27, 31, [34] [35] [36] [37] 49 However, much debate exists given that the authors of some studies have claimed that a more restricted resection such as SelAH offers advantages in terms of seizure outcome, 6, 43, 49 whereas others have not found significant differences between the 2 types of surgery. 2, 35, 36 The comparison between 2 modalities is difficult because most centers usually perform 1 preferred procedure and comparison usually relies on the results reported by other centers. To our knowledge, there have been only 5 studies in which the authors specifically compared the surgical results of CorAH and SelAH in terms of seizure outcome at a single center. 2, 3, 18, 35, 36 The first study was from our center and included 74 patients with MTLE/HS. 2 The CorAH and SelAH procedures were performed in an equal number of patients (37 in both groups), and the results in terms of seizure outcome were compared. No statistically significant difference was found between the 2 procedures in seizure control at the 1-year follow-up. Patients with unilateral atrophy had significantly better results than those with bilateral or no atrophy. The authors concluded that better results were achieved with SelAH as a more conservative procedure. This study included patients with uni-or bilateral hippocampal atrophy or patients with no atrophy, and the follow-up period was short.
The authors of the second study compared the results in terms of seizure outcome at the 1-year follow-up of 72 and 28 patients who underwent CorAH and SelAH, respectively. 18 They found that CorAH was more effective than SelAH in terms of seizure control. However, these authors also evaluated the results with a rather short-term followup, and the patients had different types of pathological entities within the temporal lobe.
The third study compared long-term seizure outcome in 79 patients who underwent CorAH and in 56 patients who underwent SelAH. 35 At the 10-year follow-up, no significant difference in the achievement of Engel Class Ia was found between the 2 groups, and survival analysis showed the rate of seizure freedom (Engel Class Ia) decreased from 85 to 74% between the 1st and 5th year after surgery. The rate of seizure freedom was found to be 66% at 10 years. The authors suggested that less favorable surgical outcomes for MTLE/HS over the years should not be systematically attributed to the remaining temporal neocortex or to the preservation of the posterior portion of the hippocampus. However, they did not mention whether the patients specified as seizure free or Engel Class Ia had an aura.
In the fourth study, no statistically significant difference was found in 80 patients with CorAH and 81 patients with SelAH in regard to Engel class or subclass at the 6.7-year (for CorAH) and 4.5-year (for SelAH) follow-up periods. 36 A recently published study compared the seizure outcome at the 1-year follow-up of patients who had CorAH (82 patients) and those who had SelAH (32 patients), and a statistically significant difference between these 2 surgical types was found. 3 The authors concluded that CorAH was
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Epilepsy surgery The authors of the fifth study compared unequal numbers of patients in each group after a short follow-up time. We reported findings that were similar to those of Arruda et al. 2 and Paglioli et al., 35, 36 who compared CorAH and SelAH in a homogeneous large group of patients with MTLE/HS after long-term follow-up. Our results demonstrated that the rate of seizure freedom without aura (Engel Class Ia) ranged from 73 to 49% at 1 and 5 years after surgery, respectively. In a large cohort of patients with MTLE of various origins, Clusmann and colleagues 7 reported findings similar to ours and stated that seizure outcome is mainly dependent on diagnosis and clinical factors.
Surgical Methods
In this study, we found that both surgical strategies are effective and that there is no significant difference in terms of seizure outcome at long-term follow-up. At MNI, our surgical strategy changed in 1990; the cohorts in the present study were chosen according to resection strategies and were not randomized. Before 1990, CorAH was the surgical procedure of choice and included anterior temporal lobe resection plus AH (first cohort). After 1990, with systemic use of neuronavigation and great advances in neuroimaging and diagnostic modalities including invasive (frameless, neuronavigation-based inserted depth electrodes since 1992 at MNI) and noninvasive preoperative EEG evaluations, we have attempted to limit resections to the presumed epileptogenic focus; therefore SelAH became the method of choice (the second cohort). We chose the transcortical SelAH approach initially proposed by Niemeyer 25 to avoid manipulation of the sylvian vessels and to prevent disconnection of the anterior portion of the temporal stem, which can result from the transsylvian technique. The main finding regarding these 2 cohorts is that despite the reduction in the amount of resected tissue, the success rate remained stable. A comparison of CorAH and SelAH performed in this series revealed a similar rate of seizure control: a satisfactory seizure control (Classes I and II) at the 5-year follow-up was achieved in 82 and 90% of patients in the CorAH and SelAH groups, respectively. When we compare subclasses, the results are also similar. For 50 patients in the CorAH group, the frequency falling into each of the Engel classes are as follows: Ia (40%), Ib (10%), Ic (6%), Id (8%), IIa (8%), IIb (4%), IIc (6%), IIIa (10%), IIIb (2%), and IVa (6%). For 50 patients who underwent SelAH, the frequencies are as follows: Ia (58%), Ib (6%), IIa (22%), IIc (2%), IId (2%), and IIIa (10%). No patient in either group experienced worsened seizure frequency (Engel Class IVb) following surgery at the 5-year follow-up (Table 2) . On reviewing the literature, we found that there is no common consensus stating that the extent of the resection has an effect on seizure outcome. The authors of some studies have reported that the extent of the mesial temporal resection had no effect, 14, 15, 40, 45 but others have reported that a greater extent of mesial temporal resection (in patients with a mesial or unilateral anterior temporal lobe focus) had a significant association with good outcome. 5, 13, 24, 26, 51 It should be noted that if the site of seizure origin resides in the damaged structures then these should be resected as radically and selectively as possible. 31 The larger cortical removal in standard resection should not become, or remain, simply a method of exposing the limbic structures. 31 Finally, the transcortical SelAH approach has the great advantage of minimizing or completely abolishing the impact of dividing several venous and arterial blood vessels, which is tedious, time consuming, and, at times, associated with some degree of cerebral swelling. 31 
Postoperative Complications
There were no surgery-related significant neurological deficits and deaths in this series. Surgery-related complications were seen in only 4 patients (4%). This rate compares favorably with the reported rate ranging from 4 to 5.4% in larger studies. 39, 41, 43, 46, 49 In our study, only 1 patient in the SelAH group experienced a complication (upper quadrantanopia). In the CorAH group, subgaleal fluid accumulation was encountered in 1 patient, and it completely resolved after insertion of a lumbar catheter. One patient had a postoperative noncompressive epidural hematoma; by the time of hospital discharge it had resolved completely. Nonoperative complications, namely pulmonary edema, were seen in 2 patients in the CorAH group and were treated using anticoagulation therapy; the patients suffered no sequela. In addition, 1 patient in the CorAH group exhibited upper quadrantanopia. We stress that the definition of a complication may be open for discussion given that some postoperative disturbances have been considered as acceptable side effects and not as complications if they resolved completely within a few days. Thus, for example, brain edema may cause simple transient side effects such as dysnomia, mild hemiparesis, aphasia, and numbness in extremities, which generally resolve after antiedema medication. Furthermore, some permanent visual field defects should also not be classified as complications, because they may be unavoidable in both surgical techniques. In this series, the overall rate of morbidity related to surgery amounted to 4%, which is well within the range of those in the literature. 39, 41, 43, 46, 49 
Methodological Limitations
We realize that there are methodological limitations to the study. First, this study is retrospective, and we did not randomize the patients to either operation. Second, the study should have included a large population of patients, and we included limited number of patients (50) in each group. Therefore, the likelihood of Type II errors may be high, which account for the high proportion of null or inconclusive findings. Although the desired power in cohort studies is usually 80-90%, the statistical power of our study was found to be 76%. Thus, we suggest that future studies should be prospective and randomized and include a greater number of patients.
Conclusions
In this study, we have demonstrated that 2 basic surgical modalities used in the treatment of patients with MTLE/HS can lead to similar favorable seizure control. Approximately 82-90% of patients who had undergone either CorAH or SelAH had attained a favorable outcome at the 5-year follow-up, and both procedures were similarly associated with no difference in terms of seizure outcome. Thus, seizure freedom is likely not to be a decisive factor in favoring one technique over the other. Temporal en bloc lobectomy may still have its place in specific instances. However, the advances in intracranial recording and brain imaging, as well as consideration of patients with impaired memory, has imposed on the surgeon the need to consider various types of resection individualized for each patient. Over the last 20 years, there has been a definite trend in reducing the extent of neocortical resection and increasing the amount of removal of limbic structures. This has led surgeons in many centers to use, more and more frequently, selective limbic removal through a variety of approaches. We have found that the transcortical selective approach has the great advantage of minimizing or completely abolishing the impact of dividing several venous and arterial blood vessels which are tedious, time consuming and, at times, associated with some degree of cerebral swelling.
